Access and Evidence
A burning desire to make a difference for patients
Annexus Health, eyeforpharma’s 2020 Health Start-up winner is on a mission for patients
More Access and Evidence Articles
Access and Evidence
From reactive to predictive: Concerto’s new compositions
Artificial Intelligence has only just begun to unlock high value innovation. The latest predictive tools will break new ground, says Concerto HealthAI’s Jeff Elton
Access and Evidence
Evolving HTA frameworks to accelerate innovation
Iterative evidence generation and demonstrating value over time could help unlock delays in getting cures out, saving more lives, says Janssen’s Clare Hague
Access and Evidence
Can we afford to pay for future cures?
Medical innovation is racing ahead of healthcare’s ability to innovate on payments, but new ideas are emerging
Access and Evidence
Into pharma's roaring twenties
A new decade is here. And despite the incredible science, pharma is ill-equipped.
Access and Evidence
Advancing RWE together with academia
Pharma can realise the potential of RWE faster by collaborating more effectively with academia but first it must build trust
Access and Evidence
Prescription drug pricing: The times they are a changin’
The political mood in the US on drug pricing at a national and state level is putting the pressure on pharma to demonstrate value
Access and Evidence
Putting a price on life: Is the answer outside pharma?
Gene replacement and cell-based therapies are here to cure, but are we ready for them? The current difficulty pricing groundbreaking healthcare advancements suggests maybe not.
Access and Evidence
Putting The I in Pills
Individualised medicine has so far failed to live up to the hype but innovations in the field are on the cusp of disrupting the way pharma and healthcare develop and provide treatments.
Access and Evidence
Embracing Early Access
Compassionate use programs offer hope to patients who have ran out of options. But the benefits must be weighed against the risks.